Education
Four patient subgroups, each defined by the mechanism that dominates.
Long COVID is not one disease. Patients tend to cluster into endotypes, which are subgroups defined by the mechanism that dominates. Each has its own characteristic symptoms and markers and its own treatment implications. Many people overlap more than one endotype.
PACVS. These endotypes were described in Long COVID. Because PACVS shares much of the same biology, the same framework is a reasonable starting hypothesis, but PACVS has not yet been formally endotyped.
The treatment-response evidence below comes from case series, case reports and observational data. None of it is from randomised trials.
Viral RNA or spike antigen persists in tissue reservoirs such as gut epithelium and lymphoid tissue. Symptoms are often gut-predominant and inflammatory markers are elevated.
GPCR autoantibodies against β-adrenergic, muscarinic and angiotensin AT1 receptors, with prominent dysautonomia and relapsing flares. This is the endotype most consistently described in PACVS cohorts.
Severe, reproducible post-exertional malaise with heavy overlap with ME/CFS. Energy metabolism fails under load.
Micro-clot burden, impaired endothelial function, and oxygen desaturation on exertion even though resting tests are normal.
Each organ system shows a characteristic marker signature. ↑ raised, ↓ lowered, + present.
| System | Marker changes | Clinical picture | Mechanisms |
|---|---|---|---|
| Skeletal muscle | ↑ Acylcarnitines ↓ TCA cycle flux | Post-exertional malaise, exercise intolerance | Mitochondria & metabolism, Vascular & clotting |
| Gut & microbiome | ↓ Serotonin ↓ Butyrate | Altered bowel habit, bloating, food intolerance | Persistent antigen, Immune dysregulation |
| Blood & coagulation | + Micro-clots ↓ RBC deformability | Exertional breathlessness, cold extremities | Vascular & clotting |
| Brain & brainstem | ↑ Kynurenine ↑ Quinolinic acid | Cognitive slowing, unrefreshing sleep, dysautonomia | Neuroinflammation, Immune dysregulation |
| Heart & endothelium | ↓ Arginine ↑ ADMA | Palpitations, chest tightness, orthostatic intolerance | Vascular & clotting, Autonomic & nerve |
| Lungs | ↑ Lactate ↓ Gas exchange | Breathlessness on exertion, air hunger | Vascular & clotting |
| Lymphoid tissue | + Spike antigen + HERV reactivation | Tender lymph nodes, sore throat, flu-like relapses | Persistent antigen, Immune dysregulation |
| Liver & bile acids | ↓ Bile acids ↑ Sphingolipids | Alcohol intolerance, post-prandial fatigue | Mitochondria & metabolism |
Testing a therapy in an unselected population dilutes any benefit concentrated in one endotype. Studies stratified by endotype are needed.
Graded exercise therapy harms the metabolic/PEM-dominant group, so activity advice should be tailored to the endotype.
Diagnosis is still clinical. Specialist metabolomic and immunological assays exist but are not standard care, which is a major gap in translating research into practice.
Endotypes often overlap. A common approach is to address the dominant mechanism first, then secondary pathology.
Educational summary only, not medical advice.
The central hub for open-source medical research and collaborative science.
Open-access research infrastructure supporting data sharing, methodology, and reproducibility.
A comprehensive resource on spike protein pathology, persistence, and therapeutic approaches.
Data-driven tools and resources for navigating vaccine safety and efficacy information.
Consensus-driven PACVS research linking clinicians, scientists, and patient partners.